![Members of the Mass General Cancer Center INCIPIENT team (from left to right): Elizabeth Gerstner, MD, William Curry, MD, Marcela Maus, MD, PhD, Bryan Choi, MD, PhD, Kathleen Gallagher, PhD and Matthew Frigault, MD. Members of the Mass General Cancer Center INCIPIENT team (from left to right): Elizabeth Gerstner, MD, William Curry, MD, Marcela Maus, MD, PhD, Bryan Choi, MD, PhD, Kathleen Gallagher, PhD and Matthew Frigault, MD.](/assets/MGH/images/cancer-center/immunotherapy/incipient-team-photo-1000x600.jpg)
Preliminary Clinical Trial Results Show ‘Dramatic and Rapid’ Regression of Glioblastoma after Next Generation CAR-T Therapy
A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment.
Read more